微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例-分子影像学杂志.pdfVIP

分子影像学分子影像第年第3737卷第卷第44期期 doi 10.3969/j.issn. 1674-4500.2014.04.07 ·241 · 临床研究 微创手术取注射式隆乳剂聚丙烯酰胺水凝胶微创手术取注射式隆乳剂聚丙烯酰胺水凝胶3535 例例 朱 婧，朱大江，陈双全，马 诺，宋锦文 佛山市妇幼保健院乳腺疾病防治中心，广东 佛山 528000 摘要：目的探讨注射式隆乳剂聚丙烯酰胺水凝胶微创手术取出的可行性并总结手术经验。方法 35 例共58 只乳腺注射式隆乳 剂PAHG 患者，32 例共52 只乳房在腔镜辅助下行取出术，3 例共5 只乳腺PAHG 位于腺体内或皮下，通过麦默通微创取出，对切 口选择、手术效果及手术经验进行总结。结果 52 只乳房PAHG 注射式隆乳剂在腔镜辅助下绝大部分被取出，术后3~6 月随访， 高频超声检查48 只乳腺未发现PAHG 残留，4 只乳房外下象限见少量PAHG 残留，其中2 只乳房合并腺体内PAHG 无回声结 节。5 只乳房行麦默通微创手术取出，术后3~6 月随访未发现PAHG 残留。结论 微创腔镜辅助下注射隆胸PAHG 取出术可去 除后间隙大部分PAHG ，对于腺体内或皮下PAHG 可行麦默通微创手术取出，手术损伤小，安全、可靠，术后切口美观，在临床上 有一定的应用价值。 关键词：聚丙烯酰胺水凝胶；注射式隆乳；腔镜；麦默通；微创 Remove injection augmentation agent polyacrylamide hydrogel by minimally invasive surgery 35 cases report ZHU Jing, ZHU Dajiang, CHEN shuangquan, MA Nuo, SONG Jinwen The Center of Breast Diseases, Maternal and Children Healthcare Hospital of Foshan City, Foshan 528000, China Abstract: Objective To explore the feasibility and conclude experiment of an operation in which removing the injection augmentation agent polyacrylamide hydrogel under minimally invasive surgery. Methods All 58 breasts in 35 patients were removed PAHG, 52 breasts in 32 patients with endoscope-assisted and 5 breasts in 3 patients whose injection located in the subcutaneous or mammary gland were removed by mammotome. It has draw a conclusion about the selection of the best incision and effect and experiment of operation. Results A majority of polyacrylamide hydrogel be removed under endoscope-assisted in 52 breast. Follow-up 3 to 6 months by high frequency ultrasound, showed no discovered polyacrylamide hydrogel in 48 breasts, but in 4 breasts were discovered located in the subcutaneous and 2 of them complicated with no echo nodules in mammary gland. 5 breasts revomed the injection by mammotome, follow-up 3 to 6 months showed no discove